To compare the bioavailability and pharmacokinetics of CAT-354 following subcutaneous administration of 150 milligram (mg) and 300 mg compared with 150 mg given intravenously.
To compare bioavailability and pharmacokinetics of CAT-354 following subcutaneous administration compared with intravenous administration.